Therapeutic Asset Ratings
423 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Shr-3792
Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P1
C
(36)
Shr-3821
Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P1
C
(36)
Shr-4849
Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P1
C
(36)
Shr-7367
Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
P1
C
(36)
Sibp-A19
Cancer
Shanghai Institute Of Biological Products
P1
C
(36)
Sigx1094R
Cancer
Signet Therapeutics
P1
C
(36)
sim0348
Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.
P1
C
(36)
SIM0501
Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.
P1
C
(36)
sim0505 for
Cancer
NextCure, Inc.
P1
C
(36)
SIM0508
Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.
P1
C
(36)
skb315 for
Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
P1
C
(36)
skb410 for
Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
P1
C
(36)
skb445 for
Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
P1
C
(36)
skb500
Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
P1
C
(36)
skb518 for
Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
P1
C
(36)
st-01156
Cancer
SEED Therapeutics, Inc.
P1
C
(36)
Syhx2005
Cancer
CSPC Ouyi Pharmaceutical Co., Ltd.
P1
C
(36)
syn818
Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
P1
C
(36)
Tagitanlimab
Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
P1
C
(36)
Tc-N201 Cells
Cancer
TCRCure Biopharma Ltd.
P1
C
(36)
Tev-56278
Cancer
Teva Branded Pharmaceutical Products R&D LLC
P1
C
(36)
tgw101
Cancer
Tagworks Pharmaceuticals BV
P1
C
(36)
Tyra-430
Cancer
Tyra Biosciences, Inc
P1
C
(36)
Universal Chimeric Natural Killer Receptor Modified T-Cells
Cancer
Zhejiang University
P1
C
(36)
Vvd-130037
Cancer
Vividion Therapeutics, Inc.
P1
C
(36)
Showing 351 to 375 of 423 assets
Previous
Page 15 of 17
Next
